Aurinia Pharmaceuticals Inc.

DB:IKAP Stock Report

Market Cap: €1.2b

Aurinia Pharmaceuticals Inc. Company Information

Aurinia Pharmaceuticals Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Aurinia Pharmaceuticals Inc.
  • Ticker: IKAP
  • Exchange: DB
  • Founded: 1993
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$1.269b
  • Listing Market Cap: US$1.209b
  • Shares Outstanding: 143.18m
  • Website: https://www.auriniapharma.com

Number of Employees

Location

  • Aurinia Pharmaceuticals Inc.
  • 118 Avenue , 14315
  • Suite 140
  • Edmonton
  • Alberta
  • T5L 4S6
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
IKAPDB (Deutsche Boerse AG)YesCommon SharesDEEURJan 1999
AUPHNasdaqGM (Nasdaq Global Market)YesCommon SharesUSUSDJan 1999

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/25 13:05
End of Day Share Price 2024/11/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.